Holdings
Profund Vp Pharmaceuticals
As of Jun 30, 2026, Profund Vp Pharmaceuticals reported 65 positions worth US$11.2M. Largest: Definium Therapeutics, Inc., Mbx Biosciences, Inc. and Alumis Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Definium Therapeutics, Inc. | 7,334 | US$345K | −2,719 | Jun 30, 2026 |
| Mbx Biosciences, Inc. | 5,500 | US$304K | −869 | Jun 30, 2026 |
| Alumis Inc. | 8,497 | US$239K | +1,387 | Jun 30, 2026 |
| Ataibeckley Inc. | 45,092 | US$238K | new | Jun 30, 2026 |
| Trevi Therapeutics, Inc. | 12,720 | US$237K | −2,966 | Jun 30, 2026 |
| Enliven Therapeutics, Inc. | 4,607 | US$234K | −1,494 | Jun 30, 2026 |
| Amylyx Pharmaceuticals, Inc. | 12,663 | US$227K | +119 | Jun 30, 2026 |
| Veradermics, Incorporated | 1,833 | US$225K | new | Jun 30, 2026 |
| Ligand Pharmaceuticals Incorporated | 687 | US$217K | −160 | Jun 30, 2026 |
| Nuvation Bio Inc. | 37,216 | US$211K | −3,587 | Jun 30, 2026 |